Olema Pharmaceuticals, Inc. - Enterprise Value

The Enterprise Value as of June 2026 (TTM) for Olema Pharmaceuticals, Inc. (OLMA) is 779.08M

According to Olema Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 779.08M. This represents a change of -35.64% compared to the average of 1.21B of the last 4 quarters.

Olema Pharmaceuticals, Inc. (OLMA) Historical Enterprise Value (quarterly & annually)

How has OLMA Enterprise Value performed in the past?

The mean historical Enterprise Value of Olema Pharmaceuticals, Inc. over the last ten years is 943.09M. The current 779.08M Enterprise Value has changed 8.16% with respect to the historical average. Over the past ten years (40 quarters), OLMA's Enterprise Value was at its highest in in the December 2025 quarter at 2.24B. The Enterprise Value was at its lowest in in the March 2020 quarter at 0.

Olema Pharmaceuticals, Inc. (OLMA) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Olema Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Olema Pharmaceuticals, Inc. (OLMA) Average Enterprise Value

How has OLMA Enterprise Value performed in the past?

The current Enterprise Value of Olema Pharmaceuticals, Inc. (OLMA) is less than than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Olema Pharmaceuticals, Inc. (OLMA) Enterprise Value vs. Peers

How is OLMA’s Enterprise Value compared to its peers?

Olema Pharmaceuticals, Inc.’s Enterprise Value is less than Ventyx Biosciences, Inc. (982.56M), less than Corvus Pharmaceuticals, Inc. (962.25M), less than Absci Corporation (1.15B), greater than REGENXBIO Inc. (459.08M), greater than Gossamer Bio, Inc. (201.31M), greater than Prothena Corporation plc (145.71M), greater than Verastem, Inc. (205.50M), less than KalVista Pharmaceuticals, Inc. (1.49B), greater than 4D Molecular Therapeutics, Inc. (453.04M), less than Lexicon Pharmaceuticals, Inc. (912.45M),

Build a custom stock screener for Olema Pharmaceuticals, Inc. (OLMA) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Olema Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Olema Pharmaceuticals, Inc. (OLMA) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Olema Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.